secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sage Therapeutics, Inc. (—)
CIK:        0001597553
Form:       8-K
Filed at:   2024-11-26T23:59:59+00:00
Accession:  0001193125-24-266154
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sage Therapeutics director Jeffrey M. Jonas to retire from Board effective Dec 1, 2024
--------------------------------------------------------------------------------

- Jeffrey M. Jonas notified the Board of his retirement effective December 1, 2024.
- Retirement not due to any disagreement with the Company on operations, policies, or practices.
- Jonas served as a member of the Board prior to retirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1597553/000119312524266154/0001193125-24-266154-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1597553/000119312524266154/d865403d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-266154

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer